Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Prognostic significance of recurring chromosomal abnormalities in transplanted patients
with acute myeloid leukemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …